直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

PTAB Strictly Applies Regulations Governing Requests for Rehearing

July 17, 2013

Practitioners facing a denied petition for inter partes review might take comfort in knowing that the AIA permits a request for rehearing. However, regulations establish a high hurdle for succeeding on any such request. And the PTAB has strictly applied those regulations to deny nearly every request for rehearing to date.

The rules governing IPRs must “be construed to secure the just, speedy, and inexpensive resolution of every proceeding.” Given the need for speedy disposition, the PTAB places the onus on the petitioner to clearly explain their positions in the petition and regularly denies requests for rehearing that merely elaborate on petitioner’s original positions or advocate invalidity grounds deemed redundant by the Board. See Schrader-Bridgeport Int’l, Inc. v. Continental Auto. Sys. US, Inc., IPR2012-00014, Paper 15 at 2 (April 10, 2013).

In addition, the petitioner bears “the burden of showing a decision should be modified” and the decision itself is reviewed for an abuse of discretion. In particular, a request for rehearing must “specifically identify all matters the party believes the Board misapprehended or overlooked, and the place where each matter was previously addressed.” The Board has strictly construed this requirement, finding requests that assert the Board misapprehended the facts insufficient to justify modification of the decision. Indeed, the Board has denied requests to reconsider technical readings of prior art and invalidity arguments, stating such arguments in the petition were unpersuasive, underdeveloped, or lacked adequate support. See Corning Inc. v. DSM IP Assets B.V., IPR2013-00052, Paper 16 (May 28, 2013).

To date, the Board has granted requests for rehearing only to the extent they established the Board misapprehended or misapplied the law. For example, the Board has determined that it erred in applying the law governing incorporation by reference and reversed its decision denying review of claims alleged to be anticipated. Illumina, Inc. v. Columbia Univ., IPR2012-00006, Paper 43 at 2-7 (May 10, 2013).

Though a rehearing is possible, practitioners should take care to fully explain in the petition all grounds of invalidity asserted. Should a request for rehearing prove necessary, those requests that cite a misapplication or misapprehension of the law, rather than those that reargue the facts, are more likely to cause the Board to modify its decision.

Copyright © 2013 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Articles

COPPA’s Amended Rule Is Now in Full Effect: What Operators Need to Know

May 15, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP